Retrophin Inc (RTRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
24.25 -0.11 (-0.45%) 11/18/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 24.25 unch (unch) -
for Wed, Nov 18th, 2020
Results
download Want to compare other data? Select Fields| Symbol | RTRX | AZN | AMGN | GILD | VRTX |
| Company | Retrophin Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 24.57 | 77.64 | 316.70 | 111.85 | 505.20 |
| High | 24.74 | 77.64 | 316.70 | 111.85 | 517.20 |
| Low | 24.04 | 77.64 | 316.70 | 111.85 | 504.00 |
| Last | 24.25 | 77.37 | 316.33 | 111.83 | 510.21 |
| Change | -0.11 | +0.27 | -0.84 | -0.43 | -3.55 |
| % Change | -0.45% | +0.35% | -0.26% | -0.38% | -0.69% |
| Volume | 378,900 | 75,539 | 2,053 | 3,151 | 1,108,900 |
| 20-Day Average Volume | 335,225 | 6,020,977 | 2,991,393 | 9,148,987 | 1,378,745 |
| Previous Close | 24.36 | 77.37 | 317.17 | 112.26 | 504.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.07 | 76.06 | 312.10 | 113.06 | 486.71 |
| 20-Day Raw Stochastic | 86.95% | 85.15% | 56.49% | 45.05% | 91.25% |
| 20-Day Relative Strength | 67.64% | 62.96% | 60.25% | 60.19% | 66.68% |
| Weighted Alpha | +75.80 | +15.51 | +13.85 | +63.63 | +24.80 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.04% since 11/11/20 | +4.58% since 03/11/25 | -0.69% since 03/11/25 | -2.25% since 03/11/25 | +2.75% since 03/10/25 |
| Low | 23.33 on 11/13/20 | 74.68 on 03/12/25 | 308.64 on 03/12/25 | 109.46 on 03/17/25 | 480.28 on 03/11/25 |
| High | 24.74 on 11/18/20 | 77.76 on 03/17/25 | 318.66 on 03/17/25 | 115.46 on 03/13/25 | 519.68 on 03/14/25 |
| 1-Month | |||||
| %Chg | +10.78% since 10/16/20 | +3.80% since 02/18/25 | +8.16% since 02/18/25 | +6.27% since 02/18/25 | +11.93% since 02/14/25 |
| Low | 19.52 on 11/02/20 | 73.54 on 02/21/25 | 291.80 on 02/19/25 | 105.20 on 02/19/25 | 451.99 on 02/18/25 |
| High | 24.96 on 11/11/20 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | +31.58% since 08/18/20 | +20.11% since 12/18/24 | +22.38% since 12/18/24 | +23.33% since 12/18/24 | +9.49% since 12/17/24 |
| Low | 17.22 on 09/24/20 | 63.75 on 12/20/24 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 24.96 on 11/11/20 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +47.33% since 05/18/20 | -1.20% since 09/18/24 | -4.87% since 09/18/24 | +33.33% since 09/18/24 | +6.75% since 09/17/24 |
| Low | 14.50 on 06/11/20 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 24.96 on 11/11/20 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,238,011 | 239,936,928 | 170,385,312 | 139,802,544 | 131,928,440 |
| Shares Outstanding, K | 51,052 | 3,101,162 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 175,340,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -146,430,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 51,140,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -22,550,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.71 | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/24/20 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 11/05/20 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.88 | 15.83 | 24.17 | 0.00 |